Molecular Biotechnology

, Volume 32, Issue 3, pp 227–248

Control of the G2/M transition


DOI: 10.1385/MB:32:3:227

Cite this article as:
Stark, G.R. & Taylor, W.R. Mol Biotechnol (2006) 32: 227. doi:10.1385/MB:32:3:227


The G2 checkpoint prevents cells from entering mitosis when DNA is damaged, providing an opportunity for repair and stopping the proliferation of damaged cells. Because the G2 checkpoint helps to maintain genomic stability, it is an important focus in understanding the molecular causes of cancer. Many different methods have been used to investigate the G2 checkpoint and uncover some of the underlying mechanisms. Because cell cycle controls are highly conserved, a remarkable synergy between the genetic power of model organisms and biochemical analyses is possible and has uncovered control mechanisms that operate in many diverse species, including humans. CDC2, the cyclin-dependent kinase that normally drives cells into mitosis, is the ultimate target of pathways that mediate rapid arrest in G2 in response to DNA damage. Additional pathways ensure that the arrest is stably maintained. When mammalian cells contain damaged DNA, the p53 tumor suppressor and the Rb family of transcriptional repressors work together to downregulate a large number of genes that encode proteins required for G2 and M. Elimination of these essential cell cycle proteins helps to keep the cells arrested in G2.

Index Entries

CDC2cyclinCDKmitosisp53DNA damage

Copyright information

© Humana Press Inc 2006

Authors and Affiliations

  1. 1.Department of Molecular Biology, Lerner Research InstituteThe Cleveland Clinic FoundationCleveland
  2. 2.Department of Biological SciencesUniversity of ToledoToledo